These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12971592)

  • 21. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
    Guo JD; Liu GG; Christensen DB; Fu AZ
    Value Health; 2003; 6(1):18-28. PubMed ID: 12535235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed drug combinations in the treatment of hypertension: how to identify the optimal dose.
    Messerli FH; Michalewicz L
    J Hypertens Suppl; 1998 Jan; 16(1):S81-4. PubMed ID: 9534103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Minimal doses of drugs in hypertension].
    Robles NR
    Nefrologia; 2006; 26(1):10-5. PubMed ID: 16649421
    [No Abstract]   [Full Text] [Related]  

  • 25. Initial monotherapy and combination therapy and hypertension control the first year.
    Egan BM; Bandyopadhyay D; Shaftman SR; Wagner CS; Zhao Y; Yu-Isenberg KS
    Hypertension; 2012 Jun; 59(6):1124-31. PubMed ID: 22566499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale for fixed-dose combination therapy to reach lower blood pressure goals.
    Basile JN
    South Med J; 2008 Sep; 101(9):918-24. PubMed ID: 18708973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difference in blood pressure response to ACE-Inhibitor monotherapy between black and white adults with arterial hypertension: a meta-analysis of 13 clinical trials.
    Peck RN; Smart LR; Beier R; Liwa AC; Grosskurth H; Fitzgerald DW; Schmidt BM
    BMC Nephrol; 2013 Sep; 14():201. PubMed ID: 24067062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertension Prevalence and Control Among Adults: United States, 2011-2014.
    Yoon SS; Carroll MD; Fryar CD
    NCHS Data Brief; 2015 Nov; (220):1-8. PubMed ID: 26633197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Classification and risk stratification in hypertension Recommendations of the European Society for Hypertension (ESH)].
    Zidek W
    MMW Fortschr Med; 2003 Nov; 145(45):41-2. PubMed ID: 14699807
    [No Abstract]   [Full Text] [Related]  

  • 30. [Initial combination treatment of hypertension].
    Düsing R
    MMW Fortschr Med; 2004 Nov; 146(47):46-8. PubMed ID: 15624658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertension.
    Ferdinand KC; Nasser SA
    Am J Cardiovasc Drugs; 2013 Oct; 13(5):301-13. PubMed ID: 23784267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical appraisal of the guidelines from France, the UK, Europe and the USA for the management of hypertension in adults.
    Stephan D; Gaertner S; Cordeanu EM
    Arch Cardiovasc Dis; 2015; 108(8-9):453-9. PubMed ID: 26113481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary combination treatment of hypertension. Strategies for improved therapy outcomes].
    Holzgreve H
    MMW Fortschr Med; 2004 Feb; 146(7):47, 49-50. PubMed ID: 15347050
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.
    Chrysant SG
    Drugs R D; 2012 Jun; 12(2):57-64. PubMed ID: 22571394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2014 Guideline for the Management of High Blood Pressure (Eighth Joint National Committee): Take-Home Messages.
    Farooq U; Ray SG
    Med Clin North Am; 2015 Jul; 99(4):733-8. PubMed ID: 26042879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination therapy: used too little and too late?].
    Veelken R; Schmieder RE
    MMW Fortschr Med; 2008 Jun; 150(24):27-8, 30. PubMed ID: 18609771
    [No Abstract]   [Full Text] [Related]  

  • 37. The new hypertension guidelines from JNC 7: is the devil in the details?
    Textor SC; Schwartz GL; Frye RL
    Mayo Clin Proc; 2003 Sep; 78(9):1078-81. PubMed ID: 12962161
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combination for initial therapy in hypertension, is it useful?].
    Gorostidi M; Prieto-Díaz MA
    Hipertens Riesgo Vasc; 2017 Jan; 34 Suppl 1():19-24. PubMed ID: 29703398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension-related morbidity and mortality in African Americans--why we need to do better.
    Ferdinand KC; Saunders E
    J Clin Hypertens (Greenwich); 2006 Jan; 8(1 Suppl 1):21-30. PubMed ID: 16415637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches.
    Bakris GL; Weir MR;
    J Clin Hypertens (Greenwich); 2003; 5(3):202-9. PubMed ID: 12826783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.